CCL2 and neoplasm: The pro-angiogenic factors, such as VEGFA, bFGF, and MCP-1, etc., are involved in the activation, mobilization and recruitment of EPCs from the bone marrow, and the differentiation of EPCs into ECs in some ischemic diseases and during tumor growth [31,32].